UBS Group’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,100
Closed -$179K 8028
2018
Q4
$179K Hold
5,100
﹤0.01% 5042
2018
Q3
$167K Hold
5,100
﹤0.01% 5199
2018
Q2
$158K Buy
+5,100
New +$146K ﹤0.01% 5116
2017
Q3
Sell
-2,800
Closed -$92K 7910
2017
Q2
$92K Buy
+2,800
New +$92.6K ﹤0.01% 5224
2015
Q1
Sell
-600
Closed -$23K 9180
2014
Q4
$23K Buy
+600
New +$22.7K ﹤0.01% 7442

Other funds holding OHI

UBS Group's OHI Position: Q1 2026 in Review

UBS Group reduced its Omega Healthcare (OHI) stake by 20% in Q1 2026, selling an estimated $16.3M and leaving 1,470,636 shares worth $64.4M. The position accounts for 0.01% of the portfolio, ranked #1390.

UBS Group first reported a position in OHI in Q4 2014 and has held it in 46 quarters since. The position peaked at $81.1M in Q4 2025. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • UBS Group held 1,470,636 shares of Omega Healthcare worth $64.4M as of Q1 2026.
  • UBS Group sold 358,019 Omega Healthcare shares in Q1 2026, an estimated $16.3M.
  • Omega Healthcare made up 0.01% of UBS Group's portfolio in Q1 2026, its #1390 holding.
  • UBS Group first reported a position in Omega Healthcare in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Omega Healthcare position peaked at $81.1M in Q4 2025.
  • 743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.